FOXO4-DRI 10 mg

Technical Details

Dosage & Usage Guidelines

FOX04-DRI is being evaluated in a growing number of research fields, including:

• Cellular senescence and anti-aging interventions
• Tissue regeneration and wound healing models
• Neurodegenerative disease research
• Targeted cancer therapy resistance pathways

Because of its ability to clear senescent cells selectively, it has been studied alongside GHK-CU for skin and tissue rejuvenation, or BPC-157 to support musculoskeletal repair where senescence hinders recovery.

Suggested Experimental Use

• Dosage: 5–10 mg per week in cycles of 2–4 weeks
• Administration: Subcutaneous or intraperitoneal (based on research model)
• Cycle Frequency: Intermittent cycling recommended to avoid systemic senescent depletion

Peptide Stacking Options

Researchers may pair FOX04-DRI with synergistic peptides to study comprehensive regeneration and immune modulation:

• AOD 9604 – for lipolytic activity during tissue repair
• DSIP – to monitor recovery sleep and HPA axis balance post-clearing
• Cartalax – for cartilage/tendon regeneration in degenerative conditions
• Chonluten – for immune resilience during age-related lung degeneration

Safety and Legality

FOX04-DRI is for **research use only**. It is not approved by the FDA for human use and should not be administered to humans or animals outside controlled laboratory environments. While early animal models suggest selective cytotoxicity toward senescent cells, researchers should implement rigorous safety and monitoring protocols when working with senolytic peptides.

To monitor regulatory updates or peer-reviewed developments on FOX04-DRI, refer to ClinicalTrials.gov.

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions